The average one-year price target for Synthetic Biologics Inc is $ The forecasts range from a low of $ to a high of $ A stock's price target is the. Check if SYN Stock has a Buy or Sell Evaluation. SYN Stock Price (NYSE), Forecast, Predictions, Stock Analysis and Synthetics Biologics Inc News. SYNTHETIC BIOLOGICS INC. quotes and chart ; Financial instrument type: Stocks ; Market: ; - ; Volume: ; Exchanged capital: . alpina-efco.ru - Synthetic Biologics Inc ; Previous Close, ; Open, ; Bid, x N/A ; Ask, x N/A ; Day's Range, - SYN - Synthetic Biologics Inc Stock - Share Price, Short Interest, Short Squeeze, Borrow Rates (AMEX).
Synthetic Biologics share price and SYN stock charts. Free real-time prices, and the most active stock market forums in the UK. Looking to buy Synthetic Biologics Stock? View today's SYN stock price, trade commission-free, and discuss SYN stock updates with the investor community. Theriva Biologics, Inc. is a clinical stage company, which engages in the development of therapeutics to preserve the microbiome to protect and restore the. Today, the company appears to be fairly valued. Synthetic Biologics has a current Real Value of $ per share. The regular price of the company is $ Our. As of Jun the stock price of Theriva Biologics is $ What is the current market cap of Theriva Biologics? The current market capitalization of. Get Theriva Biologics Inc historical price data for TOVX stock. alpina-efco.ru has all the historical stock data including the closing price, open, high. Discover historical prices for alpina-efco.ru stock on Yahoo Finance. View daily, weekly or monthly format back to when Synthetic Biologics Inc stock was issued. Should value investors buy Synthetic Biologics stock? (SYN) share price, free cash flow, and discounted present value analysis. Synthetic Biologics Inc - United States Price History ; 6/11/, AM, , , , ; 6/10/, PM, , Synthetic Biologics, Inc. (SYN): $ · Get Rating · Component Grades · Latest SYN News From Around the Web. Synthetic Biologics (SYN) Overview. Read detailed company information including current share prices, financial summary, directors, announcements.
Should You Buy or Sell Synthetic Biologics Stock? Get The Latest SYN Stock Analysis, Price Target, Earnings Estimates, and Headlines at MarketBeat. Get Synthetic Biologics Inc. (SYN) share price today, stock analysis, stock rating, price valuation, performance, fundamentals, market cap, shareholding. Get the latest Synthetic Biologics Inc. (SYN) stock price, news, buy or sell recommendation, and investing advice from Wall Street professionals. Synthetic Biologics key metrics ; P/E · ; EV/Sales · N/A ; EV/EBITDA · ; Price/Sales · N/A ; Price/Book · The latest Synthetic Biologics stock prices, stock quotes, news, and TOVX history to help you invest and trade smarter. ROCKVILLE, Md., Sept. 30, (GLOBE NEWSWIRE) -- Synthetic Biologics, Inc. (NYSE American: SYN), a diversified clinical-stage company developing therapeutics. The Theriva Biologics Inc stock price today is What Is the Stock Symbol for Theriva Biologics Inc? The stock ticker symbol for Theriva Biologics Inc is. Synthetic Biologics, Inc. - Price History ; September , $, $ ; August , $, $ ; July , $, $ ; June , $, $ Instrument Name Synthetic Biologics Inc Instrument Symbol (SYN-A). Instrument Exchange NYSE Arca · 1D1-Day · 5D5-Days · 1M1-Month · 3M3-Months · 6M6-Months · 1Y1-Year.
All information about Theriva Biologics (SYN) - stock price, quote chart, key statistics, dividends, company news and more. The average price target for Synthetic Biologics Inc is $ This is based on 1 Wall Streets Analysts month price targets, issued in the past 3 months. In a report released yesterday, Jason McCarthy from Maxim Group maintained a Buy rating on Synthetic Biologics (SYN - Research Report), with a price target of. Synthetic Biologics Inc Stock Summary and Key Details NYSE MKT SYN: Synthetic Biologics, Inc. is a clinical stage company, which engages in the development of. Synthetic Biologics (SYN) Stock Chart & Technical Analysis Graph. Follow costs, management fees, performance fees or expenses, if applicable. Please.
Synthetic Biologics, Inc. (NYSE MKT: SYN) - Stock News Now
alpina-efco.ru provides you with Synthetic Biologics Inc share price (SYN) listed in the stock exchange, including the low, high, opening and closing price. Synthetic Biologics (SYN) Forecast & Share price [target] () | Forecast share price (forecast) & targets | SYN Forecast share price target AMEX stock. Synthetic Biologics Announces Pricing of $ Million Public Offering stock at a price of $ per share, for expected gross proceeds. Synthetic. price. %. SYN: ARCX (Stock). Synthetic Biologics Inc. OCT 12, PM EDT. $ +0%. Dividend (Fwd). $ Yield (Fwd). Annualized forward dividend yield. PRNewswire/ -- Synthetic Biologics, Inc. (NYSE MKT: SYN), a late-stage clinical company developing therapeutics focused on the gut microbiome.